首页 > 最新文献

Head and Neck-Journal for the Sciences and Specialties of the Head and Neck最新文献

英文 中文
Effects of chemoradiation and tongue exercise on swallow biomechanics and bolus kinematics. 化疗和舌运动对吞咽生物力学和栓剂运动学的影响
IF 2.3 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2024-08-16 DOI: 10.1002/hed.27899
Nicole E Schaen-Heacock, Linda M Rowe, Michelle R Ciucci, John A Russell

Background: Common treatments for head and neck cancer (radiation and chemotherapy) can lead to dysphagia; tongue exercise is a common intervention. This study aimed to assess swallow biomechanics and bolus kinematics using a well-established rat model of radiation or chemoradiation treatment to the tongue base, with or without tongue exercise intervention.

Methods: Pre- and post-treatment videofluoroscopy was conducted on 32 male Sprague-Dawley rats treated with radiation/chemoradiation and exercise/no exercise. Rats in the exercise groups completed a progressive resistance tongue training paradigm. Swallow biomechanics, bolus kinematics, jaw opening, and post-swallow respiration were assessed.

Results: Both treatments impacted outcome measures; the addition of exercise intervention showed benefit for some measures, particularly in rats treated with radiation, vs. chemoradiation.

Conclusions: Radiation and chemoradiation can significantly affect aspects of deglutition; combined treatment may result in worse outcomes. Tongue exercise intervention can mitigate deficits; more intensive intervention may be warranted in proportion to combined treatment.

背景:头颈部癌症的常见治疗方法(放疗和化疗)可导致吞咽困难;舌运动是一种常见的干预措施。本研究旨在使用一个成熟的大鼠模型,评估舌根部放疗或化疗治疗后,有无舌运动干预的吞咽生物力学和栓剂运动学:方法:对 32 只雄性 Sprague-Dawley 大鼠进行了治疗前和治疗后的视频荧光镜检查,这些大鼠分别接受了放射/化学放射治疗和运动/不运动治疗。运动组大鼠完成了渐进阻力舌训练范例。对吞咽生物力学、药丸运动学、下颌张开和吞咽后呼吸进行了评估:结果:两种治疗方法都对结果指标产生了影响;增加运动干预对某些指标有益处,尤其是在接受放射治疗的大鼠与化疗大鼠之间:结论:放疗和化疗会严重影响吞咽的各个方面;联合治疗可能会导致更糟的结果。舌部运动干预可减轻缺陷;在联合治疗的情况下,可能需要进行更密集的干预。
{"title":"Effects of chemoradiation and tongue exercise on swallow biomechanics and bolus kinematics.","authors":"Nicole E Schaen-Heacock, Linda M Rowe, Michelle R Ciucci, John A Russell","doi":"10.1002/hed.27899","DOIUrl":"https://doi.org/10.1002/hed.27899","url":null,"abstract":"<p><strong>Background: </strong>Common treatments for head and neck cancer (radiation and chemotherapy) can lead to dysphagia; tongue exercise is a common intervention. This study aimed to assess swallow biomechanics and bolus kinematics using a well-established rat model of radiation or chemoradiation treatment to the tongue base, with or without tongue exercise intervention.</p><p><strong>Methods: </strong>Pre- and post-treatment videofluoroscopy was conducted on 32 male Sprague-Dawley rats treated with radiation/chemoradiation and exercise/no exercise. Rats in the exercise groups completed a progressive resistance tongue training paradigm. Swallow biomechanics, bolus kinematics, jaw opening, and post-swallow respiration were assessed.</p><p><strong>Results: </strong>Both treatments impacted outcome measures; the addition of exercise intervention showed benefit for some measures, particularly in rats treated with radiation, vs. chemoradiation.</p><p><strong>Conclusions: </strong>Radiation and chemoradiation can significantly affect aspects of deglutition; combined treatment may result in worse outcomes. Tongue exercise intervention can mitigate deficits; more intensive intervention may be warranted in proportion to combined treatment.</p>","PeriodicalId":55072,"journal":{"name":"Head and Neck-Journal for the Sciences and Specialties of the Head and Neck","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141989593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TMEM252 inhibits epithelial-mesenchymal transition and progression in papillary thyroid carcinoma by regulating Notch1 expression. TMEM252通过调控Notch1的表达抑制甲状腺乳头状癌的上皮-间质转化和进展
IF 2.3 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2024-08-16 DOI: 10.1002/hed.27922
Shuyong Zhang, Rong Xie, Liuhuan Wang, Guoxue Fu, Chenxi Zhang, Yang Zhang, Jichun Yu

Background: Papillary thyroid carcinoma (PTC) accounts for about 85% of thyroid cancer cases. Transmembrane protein 252 (TMEM252) is a gene encoding a transmembrane protein that has only been reported to be associated with triple-negative breast cancer. Herein, we first elucidated the physiological roles and possible regulatory proteins of TMEM252 in PTC pathogenesis.

Methods: Quantitative real-time polymerase chain reaction, western blot, and immunohistochemical analyses were utilized to ascertain the relative TMEM252 expression in PTC and surrounding normal tissues. Functional investigations involved CCK-8 viability assay, EdU incorporation assay for proliferation, transwell assays for migration and invasion, and an in vivo tumor development assessment to evaluate the TMEM252-mediated regulation of tumor formation.

Results: Our results first revealed diminished TMEM252 transcript and protein expressions in PTC tissues and cell lines. TMEM252 overexpression suppressed cell proliferation through reducing p53, p21, and p16 expression. Conversely, TMEM252 depletion has opposite effects in PTC cells both in vivo. Additionally, the upregulation of TMEM252 demonstrated cell migration and invasion suppression by impeding the epithelial-mesenchymal transition (EMT) process via inhibition of the Notch pathway. Furthermore, overexpression of TMEM252 suppressed tumor growth in vivo.

Conclusion: Our study elucidates that TMEM252 suppresses PTC progression by modulating the Notch pathway. These findings underscore TMEM252 is a potential therapeutic target in managing PTC.

背景:甲状腺乳头状癌(PTC甲状腺乳头状癌(PTC)约占甲状腺癌病例的85%。跨膜蛋白252(TMEM252)是一个编码跨膜蛋白的基因,目前仅有报道称该基因与三阴性乳腺癌相关。在此,我们首先阐明了TMEM252在PTC发病机制中的生理作用和可能的调控蛋白:方法:利用实时定量聚合酶链反应、Western 印迹和免疫组化分析确定 TMEM252 在 PTC 及其周围正常组织中的相对表达。功能研究包括 CCK-8 生命力检测、EdU 增殖掺入检测、迁移和侵袭的跨孔检测,以及体内肿瘤发展评估,以评估 TMEM252 介导的肿瘤形成调控:结果:我们的研究结果首先揭示了 TMEM252 在 PTC 组织和细胞系中转录本和蛋白表达的减少。TMEM252 过表达可通过降低 p53、p21 和 p16 的表达抑制细胞增殖。相反,TMEM252 的耗竭对体内的 PTC 细胞有相反的作用。此外,TMEM252 的上调还能通过抑制 Notch 通路阻碍上皮-间质转化(EMT)过程,从而抑制细胞迁移和侵袭。此外,TMEM252的过表达抑制了肿瘤在体内的生长:我们的研究阐明了 TMEM252 可通过调节 Notch 通路抑制 PTC 的进展。这些发现强调了 TMEM252 是治疗 PTC 的潜在靶点。
{"title":"TMEM252 inhibits epithelial-mesenchymal transition and progression in papillary thyroid carcinoma by regulating Notch1 expression.","authors":"Shuyong Zhang, Rong Xie, Liuhuan Wang, Guoxue Fu, Chenxi Zhang, Yang Zhang, Jichun Yu","doi":"10.1002/hed.27922","DOIUrl":"https://doi.org/10.1002/hed.27922","url":null,"abstract":"<p><strong>Background: </strong>Papillary thyroid carcinoma (PTC) accounts for about 85% of thyroid cancer cases. Transmembrane protein 252 (TMEM252) is a gene encoding a transmembrane protein that has only been reported to be associated with triple-negative breast cancer. Herein, we first elucidated the physiological roles and possible regulatory proteins of TMEM252 in PTC pathogenesis.</p><p><strong>Methods: </strong>Quantitative real-time polymerase chain reaction, western blot, and immunohistochemical analyses were utilized to ascertain the relative TMEM252 expression in PTC and surrounding normal tissues. Functional investigations involved CCK-8 viability assay, EdU incorporation assay for proliferation, transwell assays for migration and invasion, and an in vivo tumor development assessment to evaluate the TMEM252-mediated regulation of tumor formation.</p><p><strong>Results: </strong>Our results first revealed diminished TMEM252 transcript and protein expressions in PTC tissues and cell lines. TMEM252 overexpression suppressed cell proliferation through reducing p53, p21, and p16 expression. Conversely, TMEM252 depletion has opposite effects in PTC cells both in vivo. Additionally, the upregulation of TMEM252 demonstrated cell migration and invasion suppression by impeding the epithelial-mesenchymal transition (EMT) process via inhibition of the Notch pathway. Furthermore, overexpression of TMEM252 suppressed tumor growth in vivo.</p><p><strong>Conclusion: </strong>Our study elucidates that TMEM252 suppresses PTC progression by modulating the Notch pathway. These findings underscore TMEM252 is a potential therapeutic target in managing PTC.</p>","PeriodicalId":55072,"journal":{"name":"Head and Neck-Journal for the Sciences and Specialties of the Head and Neck","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141996973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Palliative care outcome measures used in head and neck cancer: A scoping review. 头颈癌中使用的姑息治疗结果测量方法:范围综述。
IF 2.3 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2024-08-16 DOI: 10.1002/hed.27920
Shreya Sriram, Deborah Xie, Rebecca A Gersten, Christine G Gourin

Background: The palliative care (PC) needs of patients with head and neck cancer (HNC) are complex, due to high and unique symptom burdens. Uniform outcome measures are critical to assessing the impact of PC interventions in HNC.

Methods: A scoping review of outcome measures used in patients with HNC receiving PC was performed using PubMed, Embase, and Web of Science from 1980 to 2022.

Results: Of 20 eligible studies, 19 unique instruments were identified which assessed 22 physical, 5 mental, 4 social, 7 related quality of life, and 9 advanced care planning outcomes. Instruments were underutilized, with a larger number of outcomes measurable for instruments used than were reported. The average instrument assessed three domains whereas the average study only reported outcomes from two domains.

Conclusions: Comparison across studies is limited due to heterogeneity in outcome measures. Future work is needed to develop core PC outcome measures for use in HNC care.

背景:头颈部癌症(HNC)患者的姑息治疗(PC)需求非常复杂,因为他们的症状负担很高且独特。统一的结果测量方法对于评估PC干预对HNC的影响至关重要:方法:利用PubMed、Embase和Web of Science对1980年至2022年接受PC治疗的HNC患者所使用的结果测量方法进行了范围界定:结果:在 20 项符合条件的研究中,发现了 19 种独特的工具,分别评估了 22 项身体、5 项精神、4 项社会、7 项相关生活质量和 9 项晚期护理规划结果。工具的使用率较低,所使用的工具可测量的结果数量多于所报告的结果。工具平均评估了三个领域,而研究平均只报告了两个领域的结果:结论:由于结果测量的异质性,各研究之间的比较是有限的。今后需要开展工作,制定用于 HNC 护理的核心 PC 结果测量方法。
{"title":"Palliative care outcome measures used in head and neck cancer: A scoping review.","authors":"Shreya Sriram, Deborah Xie, Rebecca A Gersten, Christine G Gourin","doi":"10.1002/hed.27920","DOIUrl":"https://doi.org/10.1002/hed.27920","url":null,"abstract":"<p><strong>Background: </strong>The palliative care (PC) needs of patients with head and neck cancer (HNC) are complex, due to high and unique symptom burdens. Uniform outcome measures are critical to assessing the impact of PC interventions in HNC.</p><p><strong>Methods: </strong>A scoping review of outcome measures used in patients with HNC receiving PC was performed using PubMed, Embase, and Web of Science from 1980 to 2022.</p><p><strong>Results: </strong>Of 20 eligible studies, 19 unique instruments were identified which assessed 22 physical, 5 mental, 4 social, 7 related quality of life, and 9 advanced care planning outcomes. Instruments were underutilized, with a larger number of outcomes measurable for instruments used than were reported. The average instrument assessed three domains whereas the average study only reported outcomes from two domains.</p><p><strong>Conclusions: </strong>Comparison across studies is limited due to heterogeneity in outcome measures. Future work is needed to develop core PC outcome measures for use in HNC care.</p>","PeriodicalId":55072,"journal":{"name":"Head and Neck-Journal for the Sciences and Specialties of the Head and Neck","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141996972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Presence of postlaryngectomy pseudodiverticulum on barium swallow does not affect early dietary progression. 喉切除术后吞钡时出现假性憩室不会影响早期饮食进展。
IF 2.3 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2024-08-15 DOI: 10.1002/hed.27921
Saikrishna Ananthapadmanabhan, Eugene Wong, Lydia Natsis, Anand Suruliraj, Niranjan Sritharan, Mark Smith, Carsten E Palme, Faruque Riffat

Background: The presence of a pseudodiverticulum of the anterior pharyngeal wall, or prominent "pharyngeal bar," is a well-known phenomenon that occurs following total laryngectomy, which can be visualized by nasolaryngoscopy or videofluoroscopy. Among the different techniques of pharyngeal reconstruction, there is higher incidence following primary vertical multilayered closure. It has been postulated to cause dysphagia and lack of dietary progression despite a paucity of data. However, the direct impact of pseudodiverticulum is less clear and anecdotally its presence and severity does not necessarily correlate with dysphagia.

Methods: A retrospective case series was performed of all consecutive patients who underwent total laryngectomy or laryngopharyngectomy between 2015 and 2022 at two tertiary head and neck institutions. All patients underwent routine videofluoroscopy postoperatively for swallow assessment. The presence of pseudodiverticulum on postoperative contrast swallow study was recorded to investigate the relationship with patient's ability to tolerate oral intake at 3 months discharge from the hospital.

Results: Of 50 laryngectomized patients (mean age 63.8 ± 10.0, 86% male), the main closure techniques were primary vertical (n = 9, 18%), primary T-closure (n = 14, 28%), and flap reconstruction (n = 27, 54%). Pseudodiverticulum was identified in 19 cases (38%). 43 patients underwent primary surgery and 30 had adjuvant radiotherapy. The presence of pseudodiverticulum was significantly associated with vertical primary closure versus non-vertical (T-closure or flap reconstruction) techniques (χ2 (df 1) = 7.4, p = 0.007, OR = 5.7, 95% CI 1.3-24.7). Pseudodiverticulum was not associated with an increased inability to tolerate solid intake or full diet compared to patients without pseudodiverticulum. 26.3% of patients with pseudodiverticulum were on full diet compared to 25.8% of patients without. The vertical closure technique showed no difference in ability to maintain solid intake compared with non-vertical closure; however, no patients were on full diet. Only one patient in the pseudodiverticulum group required surgical management during the study period for retention.

Conclusion: The presence of a pseudodiverticulum does not appear to be significantly associated with a need for postoperative dietary modification. The authors postulate that postlaryngectomy dysphagia is multifactorial with sensorimotor aperistalsis of the pharynx and cricopharyngeal stenosis. While a pseudodiverticulum is a common phenomenon, patients did not require modification of diet at higher rates than those without, and they seldom require intervention.

背景:咽前壁假憩室或突出的 "咽杆 "是全喉切除术后出现的一种众所周知的现象,可通过鼻咽喉镜或视频荧光镜观察到。在不同的咽部重建技术中,垂直多层一次闭合术的发生率较高。尽管数据匮乏,但假性咽闭合被推测会导致吞咽困难和饮食不进。然而,假性憩室的直接影响并不十分明确,而且据传闻,假性憩室的存在和严重程度并不一定与吞咽困难相关:方法:对2015年至2022年期间在两家三级头颈部医疗机构接受全喉切除术或喉咽切除术的所有连续患者进行了回顾性病例系列研究。所有患者术后均接受了常规视频荧光镜检查,以进行吞咽评估。记录术后对比吞咽检查中是否存在假性憩室,以研究其与患者出院3个月时耐受口腔摄入能力的关系:在50名喉切除术患者(平均年龄63.8 ± 10.0,86%为男性)中,主要的闭合技术为原发性垂直闭合(9人,占18%)、原发性T形闭合(14人,占28%)和皮瓣重建(27人,占54%)。有 19 例患者(38%)发现了假性憩室。43 例患者接受了初次手术,30 例接受了辅助放疗。假性憩室的存在与垂直原发闭合与非垂直(T 形闭合或皮瓣重建)技术显著相关(χ2 (df 1) = 7.4, p = 0.007, OR = 5.7, 95% CI 1.3-24.7)。与没有假性憩室的患者相比,假性憩室与不能耐受固体食物或全饮食的程度增加无关。26.3%的假性憩室患者可以完全进食,而 25.8% 的假性憩室患者不能完全进食。与非垂直闭合技术相比,垂直闭合技术在维持固体食物摄入的能力方面没有差异;但是,没有患者完全进食。假性憩室组中只有一名患者在研究期间因潴留而需要手术治疗:结论:假憩室的存在似乎与术后饮食调整的需求并无明显关联。作者推测喉切除术后吞咽困难是多因素造成的,包括咽部感觉运动性开口和环咽狭窄。虽然假性憩室是一种常见现象,但患者需要调整饮食的比例并不比没有假性憩室的患者高,而且他们很少需要干预。
{"title":"Presence of postlaryngectomy pseudodiverticulum on barium swallow does not affect early dietary progression.","authors":"Saikrishna Ananthapadmanabhan, Eugene Wong, Lydia Natsis, Anand Suruliraj, Niranjan Sritharan, Mark Smith, Carsten E Palme, Faruque Riffat","doi":"10.1002/hed.27921","DOIUrl":"https://doi.org/10.1002/hed.27921","url":null,"abstract":"<p><strong>Background: </strong>The presence of a pseudodiverticulum of the anterior pharyngeal wall, or prominent \"pharyngeal bar,\" is a well-known phenomenon that occurs following total laryngectomy, which can be visualized by nasolaryngoscopy or videofluoroscopy. Among the different techniques of pharyngeal reconstruction, there is higher incidence following primary vertical multilayered closure. It has been postulated to cause dysphagia and lack of dietary progression despite a paucity of data. However, the direct impact of pseudodiverticulum is less clear and anecdotally its presence and severity does not necessarily correlate with dysphagia.</p><p><strong>Methods: </strong>A retrospective case series was performed of all consecutive patients who underwent total laryngectomy or laryngopharyngectomy between 2015 and 2022 at two tertiary head and neck institutions. All patients underwent routine videofluoroscopy postoperatively for swallow assessment. The presence of pseudodiverticulum on postoperative contrast swallow study was recorded to investigate the relationship with patient's ability to tolerate oral intake at 3 months discharge from the hospital.</p><p><strong>Results: </strong>Of 50 laryngectomized patients (mean age 63.8 ± 10.0, 86% male), the main closure techniques were primary vertical (n = 9, 18%), primary T-closure (n = 14, 28%), and flap reconstruction (n = 27, 54%). Pseudodiverticulum was identified in 19 cases (38%). 43 patients underwent primary surgery and 30 had adjuvant radiotherapy. The presence of pseudodiverticulum was significantly associated with vertical primary closure versus non-vertical (T-closure or flap reconstruction) techniques (χ<sup>2</sup> (df 1) = 7.4, p = 0.007, OR = 5.7, 95% CI 1.3-24.7). Pseudodiverticulum was not associated with an increased inability to tolerate solid intake or full diet compared to patients without pseudodiverticulum. 26.3% of patients with pseudodiverticulum were on full diet compared to 25.8% of patients without. The vertical closure technique showed no difference in ability to maintain solid intake compared with non-vertical closure; however, no patients were on full diet. Only one patient in the pseudodiverticulum group required surgical management during the study period for retention.</p><p><strong>Conclusion: </strong>The presence of a pseudodiverticulum does not appear to be significantly associated with a need for postoperative dietary modification. The authors postulate that postlaryngectomy dysphagia is multifactorial with sensorimotor aperistalsis of the pharynx and cricopharyngeal stenosis. While a pseudodiverticulum is a common phenomenon, patients did not require modification of diet at higher rates than those without, and they seldom require intervention.</p>","PeriodicalId":55072,"journal":{"name":"Head and Neck-Journal for the Sciences and Specialties of the Head and Neck","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141984045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Examining timing of periorbital interventions in patients with upper division facial paralysis. 研究对上部面瘫患者进行眶周干预的时机。
IF 2.3 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2024-08-15 DOI: 10.1002/hed.27893
Samuel Doty, Amanda Goslawski, Claudia I Cabrera, Eve Tranchito, Nicole Fowler, Shawn Li, Jason E Thuener, Theodoros N Teknos, Rod P Rezaee, Cyrus C Rabbani, Akina Tamaki

Background: Facial paralysis is a life-altering condition that may arise from various etiologies, ranging from trauma to malignancy. Permanent facial paralysis may occur secondary to facial nerve sacrifice or irreversible damage to the nerve. In these particularly devastating cases, protection and maintaining function of the eye is paramount. There are many effective lagophthalmos corrective surgical procedures available for these patients. While placement of eyelid weights and lid tightening surgeries are the cornerstone of eyelid rehabilitation, limited information exists on whether the timing of eyelid interventions in the setting of permanent facial paralysis impact outcomes, including need for revision surgery.

Methods: A single-center retrospective chart review was performed for patients with irreversible facial paralysis treated with an upper eyelid weight between 2013 to 2022. Electronic health records were acquired to obtain facial paralysis etiology, associated clinical characteristics, the type of intervention, and the timing of intervention. Patients were classified as immediate if the eyelid weight operation occurred within 29 days of the initial facial paralysis and delayed if the surgery occurred 30 days or more after initial presentation. Outcomes were assessed in terms of revision procedures and surgical complications.

Results: There were 70 patients in total, with 35 patients in the immediate category and 35 patients in the delayed category. The most common etiology related to parotid gland pathology, and 58.6% of patients had facial paralysis from cancer-related surgeries. There were no significant differences in revision rates (p < 0.208) or in the types of procedures (p = 0.077) between the two groups. The complication rates also did not differ significantly between groups; however, there were only complications in the delayed intervention group.

Conclusions: These findings suggest there is no difference in postoperative complications between groups, including the need for revision surgeries when comparing groups with immediate or delayed intervention. Thus, treatment plans should be customized based on patient and provider preferences.

背景:从外伤到恶性肿瘤,各种病因都可能导致面瘫。永久性面瘫可能继发于面神经牺牲或面神经不可逆转的损伤。在这些极具破坏性的病例中,保护和维持眼睛的功能至关重要。对于这些患者,有许多有效的眼睑下垂矫正手术可供选择。虽然放置眼睑重物和眼睑收紧手术是眼睑康复的基石,但在永久性面瘫的情况下,眼睑干预的时机是否会影响治疗效果,包括是否需要进行翻修手术,这方面的信息十分有限:对2013年至2022年期间接受上眼睑重物治疗的不可逆面瘫患者进行了单中心回顾性病历审查。通过获取电子病历来了解面瘫病因、相关临床特征、干预类型和干预时机。如果患者在初次面瘫后29天内进行了眼睑负重手术,则被归类为即时手术;如果手术在初次面瘫后30天或更长时间内进行,则被归类为延迟手术。结果根据翻修手术和手术并发症进行评估:共有70例患者,其中35例为即刻手术,35例为延迟手术。最常见的病因与腮腺病变有关,58.6%的患者因癌症相关手术导致面瘫。翻修率没有明显差异(P这些研究结果表明,在比较立即干预组和延迟干预组时,术后并发症(包括翻修手术需求)在各组之间没有差异。因此,治疗方案应根据患者和医疗服务提供者的偏好进行定制。
{"title":"Examining timing of periorbital interventions in patients with upper division facial paralysis.","authors":"Samuel Doty, Amanda Goslawski, Claudia I Cabrera, Eve Tranchito, Nicole Fowler, Shawn Li, Jason E Thuener, Theodoros N Teknos, Rod P Rezaee, Cyrus C Rabbani, Akina Tamaki","doi":"10.1002/hed.27893","DOIUrl":"https://doi.org/10.1002/hed.27893","url":null,"abstract":"<p><strong>Background: </strong>Facial paralysis is a life-altering condition that may arise from various etiologies, ranging from trauma to malignancy. Permanent facial paralysis may occur secondary to facial nerve sacrifice or irreversible damage to the nerve. In these particularly devastating cases, protection and maintaining function of the eye is paramount. There are many effective lagophthalmos corrective surgical procedures available for these patients. While placement of eyelid weights and lid tightening surgeries are the cornerstone of eyelid rehabilitation, limited information exists on whether the timing of eyelid interventions in the setting of permanent facial paralysis impact outcomes, including need for revision surgery.</p><p><strong>Methods: </strong>A single-center retrospective chart review was performed for patients with irreversible facial paralysis treated with an upper eyelid weight between 2013 to 2022. Electronic health records were acquired to obtain facial paralysis etiology, associated clinical characteristics, the type of intervention, and the timing of intervention. Patients were classified as immediate if the eyelid weight operation occurred within 29 days of the initial facial paralysis and delayed if the surgery occurred 30 days or more after initial presentation. Outcomes were assessed in terms of revision procedures and surgical complications.</p><p><strong>Results: </strong>There were 70 patients in total, with 35 patients in the immediate category and 35 patients in the delayed category. The most common etiology related to parotid gland pathology, and 58.6% of patients had facial paralysis from cancer-related surgeries. There were no significant differences in revision rates (p < 0.208) or in the types of procedures (p = 0.077) between the two groups. The complication rates also did not differ significantly between groups; however, there were only complications in the delayed intervention group.</p><p><strong>Conclusions: </strong>These findings suggest there is no difference in postoperative complications between groups, including the need for revision surgeries when comparing groups with immediate or delayed intervention. Thus, treatment plans should be customized based on patient and provider preferences.</p>","PeriodicalId":55072,"journal":{"name":"Head and Neck-Journal for the Sciences and Specialties of the Head and Neck","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141984044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pembrolizumab plus cetuximab with neoadjuvant chemotherapy for head and neck squamous cell carcinoma. 头颈部鳞状细胞癌的 Pembrolizumab 加西妥昔单抗新辅助化疗。
IF 2.3 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2024-08-13 DOI: 10.1002/hed.27915
Zhuowei Yao, Jingshuo Wang, Yongquan Jiang, Yi Zhang, Jun Liu, Li Dai, Silin Shen, Xiang Zhou, Qiang Liu, Luying Zheng, Minfei Qian, Jiping Li

Purpose: Head and neck cancer cells commonly express programmed death ligand 1 (PD-L1) and epidermal growth factor receptor (EGFR), both of which play pivotal roles in the antitumor cellular immune response. Pembrolizumab, a PD-1 inhibitor, and cetuximab, an EGFR inhibitor, are typically effective agents combined with neoadjuvant platinum-based chemotherapy for the treatment of head and neck squamous cell carcinoma (HNSCC). This study aims to evaluate the efficacy and safety of neoadjuvant immunochemotherapy in patients with HNSCC.

Methods: Patients with HNSCC underwent radical surgery and complete cervical lymph node dissection following neoadjuvant immunochemotherapy at RenJi Hospital from January 2021 to June 2024 were retrospectively analyzed. The primary endpoint was major pathological response (MPR). We further explored the relationship between the efficacy and immune estimators.

Findings: Twenty-one patients were enrolled in this retrospective study. The MPR was 66.7%, including 11 patients who achieved a pathological complete response (pCR). The overall response rate (ORR) was 90.5%, and the complete response (CR) rate was 28.6%. The oropharynx, as the primary site, was the sensitive tumor type to neoadjuvant immunochemotherapy. The most common adverse event (AEs) was anemia (61.9%). No grade 4 AE or delayed surgery was reported. Laryngeal preservation rates were 90.9% (10/11), and pathological findings confirmed negative surgical margins for all patients. Moreover, pre-treatment peripheral lymphocyte count, monocyte count, and platelet to lymphocyte ratio (PLR) displayed a significant correlation with the treatment response.

Conclusion: Pembrolizumab plus cetuximab with chemotherapy for patients with HNSCC is a feasible and safe clinical protocol fulfilling organ preservation and life quality improvement. Pre-treatment peripheral immune estimators could help to screen patients who may respond to the neoadjuvant immunochemotherapy.

目的:头颈部癌细胞通常表达程序性死亡配体1(PD-L1)和表皮生长因子受体(EGFR),两者在抗肿瘤细胞免疫反应中发挥着关键作用。PD-1抑制剂Pembrolizumab和表皮生长因子受体抑制剂西妥昔单抗是联合新辅助铂类化疗治疗头颈部鳞状细胞癌(HNSCC)的典型有效药物。本研究旨在评估新辅助免疫化疗对HNSCC患者的疗效和安全性:方法:回顾性分析2021年1月至2024年6月期间在仁济医院接受根治术和完全颈淋巴结清扫术后新辅助免疫化疗的HNSCC患者。主要终点为主要病理反应(MPR)。我们进一步探讨了疗效与免疫估计指标之间的关系:这项回顾性研究共纳入 21 名患者。主要病理反应率为 66.7%,其中 11 名患者获得了病理完全反应(pCR)。总反应率(ORR)为 90.5%,完全反应率(CR)为 28.6%。口咽作为原发部位,是对新辅助免疫化疗敏感的肿瘤类型。最常见的不良反应是贫血(61.9%)。没有4级不良反应或手术延迟的报告。喉保留率为90.9%(10/11),病理结果证实所有患者的手术切缘均为阴性。此外,治疗前外周淋巴细胞计数、单核细胞计数和血小板与淋巴细胞比值(PLR)与治疗反应有显著相关性:Pembrolizumab联合西妥昔单抗化疗治疗HNSCC患者是一种可行且安全的临床方案,可实现器官保护和生活质量改善。治疗前外周免疫估计值有助于筛选可能对新辅助免疫化疗有反应的患者。
{"title":"Pembrolizumab plus cetuximab with neoadjuvant chemotherapy for head and neck squamous cell carcinoma.","authors":"Zhuowei Yao, Jingshuo Wang, Yongquan Jiang, Yi Zhang, Jun Liu, Li Dai, Silin Shen, Xiang Zhou, Qiang Liu, Luying Zheng, Minfei Qian, Jiping Li","doi":"10.1002/hed.27915","DOIUrl":"https://doi.org/10.1002/hed.27915","url":null,"abstract":"<p><strong>Purpose: </strong>Head and neck cancer cells commonly express programmed death ligand 1 (PD-L1) and epidermal growth factor receptor (EGFR), both of which play pivotal roles in the antitumor cellular immune response. Pembrolizumab, a PD-1 inhibitor, and cetuximab, an EGFR inhibitor, are typically effective agents combined with neoadjuvant platinum-based chemotherapy for the treatment of head and neck squamous cell carcinoma (HNSCC). This study aims to evaluate the efficacy and safety of neoadjuvant immunochemotherapy in patients with HNSCC.</p><p><strong>Methods: </strong>Patients with HNSCC underwent radical surgery and complete cervical lymph node dissection following neoadjuvant immunochemotherapy at RenJi Hospital from January 2021 to June 2024 were retrospectively analyzed. The primary endpoint was major pathological response (MPR). We further explored the relationship between the efficacy and immune estimators.</p><p><strong>Findings: </strong>Twenty-one patients were enrolled in this retrospective study. The MPR was 66.7%, including 11 patients who achieved a pathological complete response (pCR). The overall response rate (ORR) was 90.5%, and the complete response (CR) rate was 28.6%. The oropharynx, as the primary site, was the sensitive tumor type to neoadjuvant immunochemotherapy. The most common adverse event (AEs) was anemia (61.9%). No grade 4 AE or delayed surgery was reported. Laryngeal preservation rates were 90.9% (10/11), and pathological findings confirmed negative surgical margins for all patients. Moreover, pre-treatment peripheral lymphocyte count, monocyte count, and platelet to lymphocyte ratio (PLR) displayed a significant correlation with the treatment response.</p><p><strong>Conclusion: </strong>Pembrolizumab plus cetuximab with chemotherapy for patients with HNSCC is a feasible and safe clinical protocol fulfilling organ preservation and life quality improvement. Pre-treatment peripheral immune estimators could help to screen patients who may respond to the neoadjuvant immunochemotherapy.</p>","PeriodicalId":55072,"journal":{"name":"Head and Neck-Journal for the Sciences and Specialties of the Head and Neck","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141977311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sarcopenia may predict recurrence in patients with head and neck cancer. 肌少症可预测头颈癌患者的复发。
IF 2.3 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2024-08-13 DOI: 10.1002/hed.27903
Angela A Colback, Daniel V Arkfeld, Alireza Paydar, Osama Raslan, Daniel J Cates, Marianne Abouyared

Background: Malnutrition is a major consequence of head and neck cancer (HNC), often leading to decreased skeletal muscle mass and impacting survival. The goal of this study is to determine the effect of sarcopenia, as defined by skeletal muscle index (SMI), on survival in patients with HNC.

Methods: This is a retrospective review of patients with HNC treated with surgery and/or radiation at a single tertiary care institute. All had pre-treatment imaging available for skeletal muscle index (SMI) measurements, and SMI was calculated at the level of the 3rd cervical vertebra. Sarcopenia was defined as an SMI < 41 cm2/m2 in females and as <43 cm2/m2 in underweight or healthy weight males. Sarcopenia was defined as <53 cm2/m2 in overweight or obese males. Chi-square analysis was performed to compare recurrence and survival rates, and survival analysis was performed via Kaplan-Meir curve.

Results: Hundred and twelve patients with HNC were evaluated, 84 men and 28 women with an average age of 60.9 years. Tumors were primarily located in the oral cavity (24.1%) and oropharynx (42%). The majority (69.6%) underwent surgery. Mean body mass index prior to treatment was 28. Sixty-nine patients (61.6%) in our cohort had low SMI. Mean follow-up was 3.9 ± 2.2 years. Recurrence rate was 26% in those with low SMI versus 2% in those without. Patients with low SMI were more likely to have a recurrence (p = 0.02). Overall survival was 72.5% in those with low SMI and 81% in those with normal SMI (p = 0.09).

Conclusions: Defining sarcopenia as a low skeletal muscle index at the third cervical vertebra is clinically relevant. This study demonstrates that low SMI at this level, and thus sarcopenia, was strongly associated with higher rates of recurrence.

背景:营养不良是头颈癌(HNC)的一个主要后果,通常会导致骨骼肌质量下降并影响生存。本研究的目的是确定以骨骼肌指数(SMI)定义的肌肉疏松症对 HNC 患者生存的影响:这是一项回顾性研究,研究对象是在一家三级医疗机构接受手术和/或放射治疗的 HNC 患者。所有患者在治疗前都进行了骨骼肌指数(SMI)测量,SMI以第3颈椎水平计算。女性患者的 SMI 为 2/m2,体重不足或体重健康的男性患者的 SMI 为 2/m2,即为 "肌肉疏松症"。超重或肥胖男性的肌肉疏松症定义为 2/m2。对复发率和生存率进行了卡普兰-梅厄曲线生存分析:共评估了 112 名 HNC 患者,其中男性 84 人,女性 28 人,平均年龄 60.9 岁。肿瘤主要位于口腔(24.1%)和口咽(42%)。大多数患者(69.6%)接受了手术治疗。治疗前的平均体重指数为 28。69名患者(61.6%)的SMI较低。平均随访时间为 3.9 ± 2.2 年。低 SMI 患者的复发率为 26%,而非低 SMI 患者的复发率为 2%。低SMI患者更容易复发(P = 0.02)。低SMI患者的总生存率为72.5%,正常SMI患者的总生存率为81%(p = 0.09):结论:将第三颈椎处骨骼肌指数低定义为 "肌肉疏松症 "具有临床意义。本研究表明,该部位的骨骼肌指数低,因此肌肉疏松症与较高的复发率密切相关。
{"title":"Sarcopenia may predict recurrence in patients with head and neck cancer.","authors":"Angela A Colback, Daniel V Arkfeld, Alireza Paydar, Osama Raslan, Daniel J Cates, Marianne Abouyared","doi":"10.1002/hed.27903","DOIUrl":"https://doi.org/10.1002/hed.27903","url":null,"abstract":"<p><strong>Background: </strong>Malnutrition is a major consequence of head and neck cancer (HNC), often leading to decreased skeletal muscle mass and impacting survival. The goal of this study is to determine the effect of sarcopenia, as defined by skeletal muscle index (SMI), on survival in patients with HNC.</p><p><strong>Methods: </strong>This is a retrospective review of patients with HNC treated with surgery and/or radiation at a single tertiary care institute. All had pre-treatment imaging available for skeletal muscle index (SMI) measurements, and SMI was calculated at the level of the 3rd cervical vertebra. Sarcopenia was defined as an SMI < 41 cm<sup>2</sup>/m<sup>2</sup> in females and as <43 cm<sup>2</sup>/m<sup>2</sup> in underweight or healthy weight males. Sarcopenia was defined as <53 cm<sup>2</sup>/m<sup>2</sup> in overweight or obese males. Chi-square analysis was performed to compare recurrence and survival rates, and survival analysis was performed via Kaplan-Meir curve.</p><p><strong>Results: </strong>Hundred and twelve patients with HNC were evaluated, 84 men and 28 women with an average age of 60.9 years. Tumors were primarily located in the oral cavity (24.1%) and oropharynx (42%). The majority (69.6%) underwent surgery. Mean body mass index prior to treatment was 28. Sixty-nine patients (61.6%) in our cohort had low SMI. Mean follow-up was 3.9 ± 2.2 years. Recurrence rate was 26% in those with low SMI versus 2% in those without. Patients with low SMI were more likely to have a recurrence (p = 0.02). Overall survival was 72.5% in those with low SMI and 81% in those with normal SMI (p = 0.09).</p><p><strong>Conclusions: </strong>Defining sarcopenia as a low skeletal muscle index at the third cervical vertebra is clinically relevant. This study demonstrates that low SMI at this level, and thus sarcopenia, was strongly associated with higher rates of recurrence.</p>","PeriodicalId":55072,"journal":{"name":"Head and Neck-Journal for the Sciences and Specialties of the Head and Neck","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141977312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of laryngeal chondroradionecrosis: A single-center experience. 喉软骨软化症的治疗:单中心经验
IF 2.3 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2024-08-13 DOI: 10.1002/hed.27919
Einav G Levin, Amit Ritter, Gideon Bachar, Aviram Mizrachi, Hagit Shoffel-Havakuk, Noga Kurman, Aron Popovtzer, Yaniv Hamzany

Background: Laryngeal chondroradionecrosis (LCRN) is a rare but severe complication of radiation therapy. The study aimed to review the management of LCRN and evaluate the clinical benefit of hyperbaric oxygen therapy (HBOT).

Methods: We retrospectively analyzed all radiation-induced LCRN patients between 2006 and 2019 at a tertiary medical center. Diagnosis was based on signs and symptoms of Chandler's classification, imaging, and/or histopathology report. The primary outcome was improvement in Chandler's grade after HBOT.

Results: Of 678 irradiated laryngeal cancer patients, 29 (4.3%) were diagnosed with LCRN. The most common primary management was tracheostomy with intravenous steroids and antibiotics (59%). Ten patients received HBOT (34.5%), and six underwent total laryngectomy (21%). In HBOT-treated patients, Chandler's grade significantly improved from a median of 4 (range 2-4) to 2.5 (range 1-4; p = 0.005).

Conclusions: HBOT may benefit in the management of patients with persistence and unresponsive symptoms of LCRN following radiation therapy for laryngeal SCC.

背景:喉软骨软化症(LCRN)是放疗的一种罕见但严重的并发症。本研究旨在回顾LCRN的治疗方法,并评估高压氧治疗(HBOT)的临床益处:我们回顾性分析了一家三级医疗中心在 2006 年至 2019 年期间所有由放射治疗引发的 LCRN 患者。诊断依据是钱德勒分类的体征和症状、影像学和/或组织病理学报告。主要结果是 HBOT 后钱德勒分级的改善情况:结果:在678名接受过放射治疗的喉癌患者中,29人(4.3%)被诊断为LCRN。最常见的主要治疗方法是气管造口术,同时静脉注射类固醇和抗生素(59%)。10名患者接受了HBOT治疗(34.5%),6名患者接受了全喉切除术(21%)。在接受过 HBOT 治疗的患者中,钱德勒评分从中位数 4(范围 2-4)明显降低到 2.5(范围 1-4;P = 0.005):HBOT可用于治疗喉SCC放疗后LCRN症状持续存在且无反应的患者。
{"title":"Management of laryngeal chondroradionecrosis: A single-center experience.","authors":"Einav G Levin, Amit Ritter, Gideon Bachar, Aviram Mizrachi, Hagit Shoffel-Havakuk, Noga Kurman, Aron Popovtzer, Yaniv Hamzany","doi":"10.1002/hed.27919","DOIUrl":"https://doi.org/10.1002/hed.27919","url":null,"abstract":"<p><strong>Background: </strong>Laryngeal chondroradionecrosis (LCRN) is a rare but severe complication of radiation therapy. The study aimed to review the management of LCRN and evaluate the clinical benefit of hyperbaric oxygen therapy (HBOT).</p><p><strong>Methods: </strong>We retrospectively analyzed all radiation-induced LCRN patients between 2006 and 2019 at a tertiary medical center. Diagnosis was based on signs and symptoms of Chandler's classification, imaging, and/or histopathology report. The primary outcome was improvement in Chandler's grade after HBOT.</p><p><strong>Results: </strong>Of 678 irradiated laryngeal cancer patients, 29 (4.3%) were diagnosed with LCRN. The most common primary management was tracheostomy with intravenous steroids and antibiotics (59%). Ten patients received HBOT (34.5%), and six underwent total laryngectomy (21%). In HBOT-treated patients, Chandler's grade significantly improved from a median of 4 (range 2-4) to 2.5 (range 1-4; p = 0.005).</p><p><strong>Conclusions: </strong>HBOT may benefit in the management of patients with persistence and unresponsive symptoms of LCRN following radiation therapy for laryngeal SCC.</p>","PeriodicalId":55072,"journal":{"name":"Head and Neck-Journal for the Sciences and Specialties of the Head and Neck","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141977310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The lateral based nasopharyngeal flap: A novel vascularized flap for skull base reconstruction 鼻咽外侧皮瓣:用于颅底重建的新型血管化皮瓣
IF 2.3 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2024-08-12 DOI: 10.1002/hed.27911
Viraj M. Patel MD, Saad M. Alshammari MBBS, David W. Jang MD, Ali R. Zomorodi MD, Ralph Abi Hachem MD, MSc

As the indications for endoscopic skull base approaches have increased, so has the need for more versatile vascularized flaps for skull base reconstruction. Here, we describe a novel lateral based nasopharyngeal flap (LNPF). Two cadaver heads were dissected to elucidate flap anatomy, dimensions, and technique. A retrospective review was performed on two cases where LNPF was used to repair CSF leaks in the nasopharyngeal area, and outcomes reported. The LNPF is an ascending pharyngeal artery myomucosal flap that includes the nasopharyngeal mucosa and the superior pharyngeal constrictor muscle. The flap was 1.2 × 2.2 cm in greatest dimensions. The LNPF was used for salvage CSF leak repair in two cases: one clival and one tubal. Both patients had resolution of leak at 7 months follow-up. The LNPF is a novel flap with reconstruction potential for the nasopharynx, including the lower clivus and the eustachian tube.

随着内窥镜颅底手术适应症的增加,人们对用于颅底重建的多功能血管化皮瓣的需求也在增加。在这里,我们描述了一种新颖的侧位鼻咽皮瓣(LNPF)。我们解剖了两个尸体头颅,以阐明皮瓣的解剖、尺寸和技术。对两例使用 LNPF 修复鼻咽部位 CSF 渗漏的病例进行了回顾性审查,并报告了结果。LNPF 是一种咽上升动脉粘膜瓣,包括鼻咽粘膜和咽上收缩肌。皮瓣最大尺寸为 1.2 × 2.2 厘米。LNPF 用于两例脑脊液漏的抢救性修复:一例为瓣膜型,一例为输卵管型。随访 7 个月后,两名患者的漏液均已消除。LNPF 是一种新型皮瓣,具有重建鼻咽部(包括下蒂和咽鼓管)的潜力。
{"title":"The lateral based nasopharyngeal flap: A novel vascularized flap for skull base reconstruction","authors":"Viraj M. Patel MD,&nbsp;Saad M. Alshammari MBBS,&nbsp;David W. Jang MD,&nbsp;Ali R. Zomorodi MD,&nbsp;Ralph Abi Hachem MD, MSc","doi":"10.1002/hed.27911","DOIUrl":"10.1002/hed.27911","url":null,"abstract":"<p>As the indications for endoscopic skull base approaches have increased, so has the need for more versatile vascularized flaps for skull base reconstruction. Here, we describe a novel lateral based nasopharyngeal flap (LNPF). Two cadaver heads were dissected to elucidate flap anatomy, dimensions, and technique. A retrospective review was performed on two cases where LNPF was used to repair CSF leaks in the nasopharyngeal area, and outcomes reported. The LNPF is an ascending pharyngeal artery myomucosal flap that includes the nasopharyngeal mucosa and the superior pharyngeal constrictor muscle. The flap was 1.2 × 2.2 cm in greatest dimensions. The LNPF was used for salvage CSF leak repair in two cases: one clival and one tubal. Both patients had resolution of leak at 7 months follow-up. The LNPF is a novel flap with reconstruction potential for the nasopharynx, including the lower clivus and the eustachian tube.</p>","PeriodicalId":55072,"journal":{"name":"Head and Neck-Journal for the Sciences and Specialties of the Head and Neck","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141918172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transoral robotic parapharyngeal space dissection 经口机器人咽旁间隙剥离术
IF 2.3 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2024-08-12 DOI: 10.1002/hed.27902
David Virós Porcuna MD, PhD, Carlos M. Pollán Guisasola MD, Constanza Viña Soria MD, Pablo Vergés Fort MD, Mar Palau Viarnès MD, Luis Juesas Iglesias MD, Armando De Virgilio MD, PhD

Transoral robotic surgery (TORS) provides a minimally invasive approach to address tumors in selected and challenging anatomical locations. Among the critical areas where TORS demonstrates its prowess is the oropharynx. Oropharyngeal tumors can invade parapharyngeal space (PPS) which contains vital structures such as the carotid artery, internal jugular vein, and cranial nerves IX–XII. A deeper understanding of the endoscopic anatomy of the parapharyngeal space could reduce the morbidity associated with tumor resection in this dense neurovascular area. This video-article provides a step-by-step cadaveric dissection of the lower PPS though a transoral robotic approach.

经口机器人手术(TORS)提供了一种微创方法,用于治疗特定和具有挑战性解剖位置的肿瘤。其中,口咽部是 TORS 大显身手的关键部位。口咽肿瘤可侵犯咽旁间隙(PPS),而咽旁间隙包含颈动脉、颈内静脉和颅神经IX-XII等重要结构。深入了解咽旁间隙的内窥镜解剖结构可降低在这一神经血管密集区域进行肿瘤切除时的发病率。本视频文章通过经口机器人方法逐步解剖下咽旁间隙。
{"title":"Transoral robotic parapharyngeal space dissection","authors":"David Virós Porcuna MD, PhD,&nbsp;Carlos M. Pollán Guisasola MD,&nbsp;Constanza Viña Soria MD,&nbsp;Pablo Vergés Fort MD,&nbsp;Mar Palau Viarnès MD,&nbsp;Luis Juesas Iglesias MD,&nbsp;Armando De Virgilio MD, PhD","doi":"10.1002/hed.27902","DOIUrl":"10.1002/hed.27902","url":null,"abstract":"<p>Transoral robotic surgery (TORS) provides a minimally invasive approach to address tumors in selected and challenging anatomical locations. Among the critical areas where TORS demonstrates its prowess is the oropharynx. Oropharyngeal tumors can invade parapharyngeal space (PPS) which contains vital structures such as the carotid artery, internal jugular vein, and cranial nerves IX–XII. A deeper understanding of the endoscopic anatomy of the parapharyngeal space could reduce the morbidity associated with tumor resection in this dense neurovascular area. This video-article provides a step-by-step cadaveric dissection of the lower PPS though a transoral robotic approach.</p>","PeriodicalId":55072,"journal":{"name":"Head and Neck-Journal for the Sciences and Specialties of the Head and Neck","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141918184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Head and Neck-Journal for the Sciences and Specialties of the Head and Neck
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1